ANIX Anixa Biosciences Inc

ITUS Corp is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers.

As of 10/15/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  10/14/2013
Outstanding shares:  29,949,905
Average volume:  95,179
Market cap:   $136,871,066
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03528H109
ISIN:        US03528H1095
Valuation   (See tab for details)
PE ratio:   -59.54
PB ratio:   12.16
PS ratio:   267.07
Return on equity:   -24.97%
Net income %:   -1,746.58%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy